Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats

Obesity

Volumn 21, Issue 4, 2013, Pages 748-754

  Mathur, Ruchi ^a   Kim, Gene ^a   Morales, Walter ^a   Sung, Jaekyu ^a,b   Rooks, Emily ^a   Pokkunuri, Venkata ^a   Weitsman, Stacy ^a   Barlow, Gillian M ^a   Chang, Christopher ^a   Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BODY WEIGHT; CECUM; COLON; CONTROLLED STUDY; DIET INDUCED WEIGHT GAIN; DUODENUM; EUTHANASIA; ILEUM; INOCULATION; INTESTINE FLORA; LIPID DIET; METHANOBREVIBACTER SMITHII; NONHUMAN; RAT; SMALL INTESTINE; WEIGHT GAIN;

ANIMALIA; METHANOBREVIBACTER SMITHII; RATTUS;

EID: 85027935270     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20277     Document Type: Article

References (40)

1. Gill SR, Pop M, Deboy RT, et al,. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
2. Turnbaugh PJ, Ley RE, Hamady M, et al,. The human microbiome project. Nature 2007; 449: 804-810.
3. Savage DC,. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107-133.
4. Simon GL, Gorbach SL,. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-193.
5. Peled Y, Gilat T, Liberman E, Bujanover Y,. The development of methane production in childhood and adolescence. J Pediatr Gastroenterol Nutr 1985; 4: 575-579.
6. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI,. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.
7. Sahakian AB, Jee SR, Pimentel M,. Methane and the gastrointestinal tract. Dig Dis Sci 2010; 55: 2135-2143.
8. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI,. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
9. Turnbaugh PJ, Ley RE, Mahowald MA, et al,. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
10. Cani PD, Amar J, Iglesias MA, et al,. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
11. Bäckhed F, Ding H, Wang T, et al,. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
12. Ley RE, Turnbaugh PJ, Klein S, Gordon JI,. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
13. Cani PD, Bibiloni R, Knauf C, et al,. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
14. Musso G, Gambino R, Cassader M,. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62: 361-380.
15. Cani PD, Delzenne NM,. The gut microbiome as therapeutic target. Pharmacol Ther 2011; 130: 202-212.
16. Jones WJ, Nagle DP Jr, Whitman WB,. Methanogens and the diversity of archaebacteria. Microbiol Rev 1987; 51: 135-177.
17. McKay LF, Holbrook WP, Eastwood MA,. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol Microbiol Immunol Scand B 1982; 90: 257-260.
18. Gibson GR, Cummings JH, Macfarlane GT, et al,. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 1990; 31: 679-683.
19. Pimentel M, Mayer AG, Park S, et al,. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003; 48: 86-92.
20. Pimentel M, Chow EJ, Lin HC,. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 412-419.
21. Flourié B, Etanchaud F, Florent C, et al,. Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates. Gut 1990; 31: 684-685.
22. Samuel BS, Gordon JI,. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA 2006; 103: 10011-10016.
23. Mathur R, Amichai M, Mirocha J, et al,. Concomitant methane and hydrogen production in humans is associated with a higher body mass index. Gastroenterology 2011; 140: S-335.
24. Miller TL, Wolin MJ,. Methanosphaera stadtmaniae gen. nov., sp. nov.: a species that forms methane by reducing methanol with hydrogen. Arch Microbiol 1985; 141: 116-122.
25. Zhang H, DiBaise JK, Zuccolo A, et al,. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365-2370.
26. Nava GM, Carbonero F, Croix JA, Greenberg E, Gaskins HR,. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J 2012; 6: 57-70.
27. Pimentel M, Chatterjee S, Chang C, et al,. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci 2008; 53: 982-989.
28. Hooper LV, Midtvedt T, Gordon JI,. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002; 22: 283-307.
29. Ridlon JM, Kang DJ, Hylemon PB,. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47: 241-259.
30. Kim JJ, Sears DD,. TLR4 and insulin resistance. Gastroenterol Res Pract 2010; 2010: 212563.
31. Ley RE, Bäckhed F, Turnbaugh P, et al,. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
32. Chen M, Wolin MJ,. Effect of monensin and lasalocid-sodium on the growth of methanogenic and rumen saccharolytic bacteria. Appl Environ Microbiol 1979; 38: 72-77.
33. Freeland KR, Wilson C, Wolever TM,. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 2010; 103: 82-90.
34. Freeland KR, Wolever TM,. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr 2010; 103: 460-466.
35. Chatterjee S, Park S, Low K, Kong Y, Pimentel M,. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007; 102: 837-841.
36. Fiedorek SC, Pumphrey CL, Casteel HB,. Breath methane production in children with constipation and encopresis. J Pediatr Gastroenterol Nutr 1990; 10: 473-477.
37. Peled Y, Weinberg D, Hallak A, Gilat T,. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 1987; 32: 267-271.
38. Pimentel M, Lin HC, Enayati P, et al,. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1089-G1095.
39. Parkman HP, Yates K, Hasler WL, et al,. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011; 140: 101-115.
40. Kunkel D, Basseri B, Low K, et al,. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol Motil 2011; 23: 739-e328.